the earlier the better: detecting target genes in myeloproliferative neoplasms
Published 5 years ago • 200 plays • Length 4:03Download video MP4
Download video MP3
Similar videos
-
1:43
potential of next-generation sequencing in the nhs for patients with mpns
-
1:00
identifying new cll therapeutic targets by focusing on the evolution of cancer cells
-
0:45
difference between quality of life & patient-reported outcomes
-
1:34
the importance of quickly spotting the signs of aml
-
4:18
identifying risk factors for thrombosis in mpns and treatment strategies
-
4:09
risk factors for progression in mpns
-
6:37
drivers of progression in mpns and the importance of early intervention
-
8:14
chronic blood cancer at 30 | essential thrombocytosis | mpn
-
4:39
my experience with essential thrombocytosis
-
1:26:57
scientist stories: jay bradner, molecular glues for intractable targets
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
1:51
novel insights into genomic classification and prognosis in aml
-
3:35
epigenomics in precision oncology
-
4:35
the role of jak2 vaf testing in risk assessment and disease monitoring in mpns
-
0:55
adaptive licensing: a new approach for authorizing medicines
-
2:36
current knowledge of the tp53 mutation and its role in cll
-
1:36
precise™ treatment registry
-
1:33:02
the lab
-
6:07
a crispr approach to hematological research
-
2:34
get ready for the research challenge of your life!
-
2:12
social media – a useful tool for hematological research